INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
Condition(s):Diabetes Mellitus, Type 1Last Updated:February 13, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 1Last Updated:February 13, 2024Active, not recruiting
Condition(s):Respiratory FailureLast Updated:October 30, 2018Completed
Condition(s):Obstructive Sleep Apnea; Sleep Disordered BreathingLast Updated:July 5, 2023Suspended
Condition(s):Interstitial Lung DiseaseLast Updated:November 7, 2023Recruiting
Condition(s):DiabetesLast Updated:April 19, 2022Completed
Condition(s):Cancer; Cardiac Anomaly; Cystic Fibrosis; Muscular Dystrophy; HIV/AIDS; Batten’s Disease; Cerebral PalsyLast Updated:July 27, 2020Unknown status
Condition(s):AsthmaLast Updated:September 12, 2017Completed
Condition(s):Femoroacetabular Impingement SyndromeLast Updated:August 14, 2023Recruiting
Condition(s):Ocular Hypertension; Glaucoma, Open-AngleLast Updated:April 7, 2008Completed
Condition(s):Chronic Nonspecific Neck PainLast Updated:June 18, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.